Showing 1691-1700 of 3153 results for "".
Jejunal Trichobezoar in a 3-year-old Boy; Practice Path MD Pro Tip: Architects
https://practicaldermatology.com/youngmd-connect/resident-resource-center/jejunal-trichobezoar-in-a-3-year-old-boy-practice-path-md-pro-tip-architects/20697/Current Sunscreen Controversies Impeding Patient Compliance
https://practicaldermatology.com/topics/practice-management/current-sunscreen-controversies-impeding-patient-compliance/20992/Patient concerns should not prevent the physician from advising adequate sunscreen use.The Next Big Thing: Aesthetics in 2016
https://practicaldermatology.com/topics/practice-management/the-next-big-thing-aesthetics-in-2016/21035/Industry leaders share their predictions for what we will be talking about this year in aesthetic dermatology.Reach Your Customers
https://practicaldermatology.com/topics/practice-management/reach-your-customers/21079/Strategic messaging and marketing opportunities for your practice.Therapeutics Focus: Skin Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/therapeutics-focus-skin-cancer/21419/New products and pharmacologic developmentsWhat’s New in Topical Acne Treatment?
https://practicaldermatology.com/topics/acne-rosacea/whats-new-in-topical-acne-treatment/23277/Therapeutics Update
https://practicaldermatology.com/topics/psoriasis/therapeutics-update/20530/New products and pharmacologic developmentsTo Attenuate the Skin Cancer Epidemic, Start Early
https://practicaldermatology.com/topics/skin-cancer-photoprotection/to-end-the-skin-cancer-epidemic-start-early/20719/UV education and good SPF habits for children are essential to reversing worrisome skin cancer trends.Body Slimming: Exploring the Options
https://practicaldermatology.com/topics/practice-management/body-slimming-exploring-the-options/21112/Several experts share experiences and insights on the wide array of contouring devices.New Oral Agent May Shift Psoriasis Treatment Landscape
https://practicaldermatology.com/topics/psoriasis/new-oral-agent-may-shift-psoriasis-treatment-landscape/21258/A notable approval in 2014, apremilast may play an important role in bridging a wide gap in the care of moderate to severe psoriasis.